Navigation Links
New Research Could Expand Availability of Light-Based Mesothelioma Therapy, According to Surviving Mesothelioma
Date:7/14/2014

Raleigh, NC (PRWEB) July 14, 2014

The NIH is giving $8 million dollars to researchers at the University of Pennsylvania to fund a clinical trial on light-based therapy in mesothelioma surgical patients. Click here to read Surviving Mesothelioma’s newly-posted article on the research.

Scientists at the University of Pennsylvania plan to use the grant to enroll 102 pleural mesothelioma study participants over the next four years. Patients will receive a photosensitizing drug prior to surgery. Then half will have the laser light treatment during their procedure while half will have only follow-up chemotherapy.

“This trial represents a major step in understanding the combination of treatment modalities that will offer patients the best hope for survival and extended remission,” said lead investigator Eli Glatstein, MD.

Previous University of Pennsylvania studies of PDT with lung-sparing surgery have produced remarkable survival rates of up to 41 months, even in patients with advanced mesothelioma.

“PDT is an exciting emerging therapy that is currently not widely available for mesothelioma treatment,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “If the results of these new NIH-funded studies are as encouraging as the previous studies of PDT at Penn, more patients who need it may get access to this therapy.”

For details of the new PDT research at Penn, see NIH Grant May Help Validate Light-Based Therapy for Mesothelioma now available on the Surviving Mesothelioma website.

“Penn Mesothelioma Program Receives $8 Million NCI Grant to Study Effects of Photodynamic Therapy Plus Surgery on Patient Survival and Disease Progression”, July 10, 2014, News Release, University of Pennsylvania website, http://www.uphs.upenn.edu/news/News_Releases/2014/07/meso/

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12009999.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stanford researchers invent nanotech microchip to diagnose type-1 diabetes
2. Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld
3. Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com
4. Casinos in Australia Industry Market Research Report Now Updated by IBISWorld
5. Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated
6. World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com
7. Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld
8. Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld
9. Researchers Assess New Way to Boost Polio Immunity
10. USC stem cell researcher targets the seeds of breast cancer metastasis
11. Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Saint Francis Hospital ... years, and the efforts have paid off. Since implementation of these efforts, ... care to enhance perioperative patient experiences and reduce costly complications. Since implementation in ...
(Date:5/26/2016)... ... May 26, 2016 , ... Development Team of Pixel ... for FCPX. , "This new layered style transition tool will keep a consistent flow ... CEO of Pixel Film Studios. , TranSweep is an all new layered style ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... industry leader in Blood Pressure products . , High blood pressure affects ... effects. Left untreated, high blood pressure can lead to heart disease, stroke, kidney ...
(Date:5/25/2016)... ... May 26, 2016 , ... The United States Food and Drug Administration ... both men and women. To date, the company is the first and only manufacturer ... adult who suffers with androgenetic alopecia. , “This new level of clearance substantiates ...
(Date:5/25/2016)... ... 25, 2016 , ... The Georgia State University College of Law new building ... Design Commission. , The annual award recognizes projects, programs, individuals and organizations that have ... of its physical heritage and the balance between the old and the new. , ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... LONDON , May 24, 2016 ... erfüllt beide primären Endpunkte ... und Überlegenheit in ‚ausgezeichneter plus guter ... aufsteigenden Colons    ,      (Logo: ... B.V. gab heute neue positive Daten von der ...
(Date:5/24/2016)... -- NxStage Medical, Inc. (Nasdaq: NXTM ), a ... today announced that Jeffrey H. Burbank , Chief ... of investor conferences. Where applicable, a webcast of the ...   ... Friday, June 10, 2016 1:30 p.m. ET ...
(Date:5/24/2016)... HONG KONG , May 24, 2016 /PRNewswire/ ... primer stent de doble terapia del mundo, introduce ... fístula arteriovenosa. OrbusNeich, una compañía global ... cambian las vidas, ha expandido su cartera incluyendo ... catéteres balón JADE™ y Scoreflex™ PTA son los ...
Breaking Medicine Technology: